Sex-specific disparities of serum pepsinogen I in relation to body mass index

Clin Chem Lab Med. 2023 May 12;61(11):2010-2016. doi: 10.1515/cclm-2023-0236. Print 2023 Oct 26.

Abstract

Objectives: The clinical significance of serum pepsinogen (PG) for screening gastric cancer has been a controversial topic. Serum PG I levels have been demonstrated to be correlated with age, sex, and the Helicobacter pylori (HP) infection. However, the underlying factors that influence serum PG I variations remain to be fully elucidated. We aimed to evaluate the impacts of sex and body mass index (BMI) on PG I in Chinese population.

Methods: The cross-sectional study recruited 4,299 apparently healthy participants in Fujian Province. Serum PG levels were automatically measured using ELISA method. Serum H. pylori-IgG antibody was detected by the colloidal gold immunoassay. Clinical characteristics were obtained by questionnaire.

Results: Totally, 2,263 participants who had tests of serum PG and anti-HP IgG antibody were enrolled. Increased BMI and serum uric acid were observed in males with low PG I value (<70 μg/L). Multiple logistic regression showed the presence of overweight was the independent risk factor for male participants with low PG I level (odds ratio [OR] 1.519; p=0.017). However, the association was not found in females.

Conclusions: Sex-specific association of serum low PG I with overweight was observed in the southeast coastal areas of China. Thus, effects of sexual dimorphism should not be ignored during the clinical utilization of serum PG I.

Keywords: China; body mass index; overweight; pepsinogen; sex-specific.

MeSH terms

  • Body Mass Index
  • Cross-Sectional Studies
  • Female
  • Helicobacter Infections* / diagnosis
  • Helicobacter pylori*
  • Humans
  • Immunoglobulin G
  • Male
  • Overweight
  • Pepsinogen A
  • Stomach Neoplasms*
  • Uric Acid

Substances

  • Pepsinogen A
  • Uric Acid
  • Immunoglobulin G